این سایت در حال حاضر پشتیبانی نمی شود و امکان دارد داده های نشریات بروز نباشند
Iranian Journal of Pathology، جلد ۱۷، شماره ۴، صفحات ۴۱۹-۴۲۶
عنوان فارسی
چکیده فارسی مقاله
کلیدواژه‌های فارسی مقاله
عنوان انگلیسی Evaluation of FLT3-ITD Mutations and MDR1 Gene Expression in AML Patients
چکیده انگلیسی مقاله Background & Objective: Acute myeloid leukemia (AML) is a hematopoietic malignancy caused by genetic abnormalities. These days, molecular and genetic factors are usually used as diagnostic and prognostic markers. FLT-3 is one of the most known diagnostic factors in AML. MDR1 gene belongs to the ATP binding cassette family; it is known as one of the chemotherapy-resistant causes of AML. We aimed to study FLT-3ITD mutations and their association with MDR1 gene expression in AML individuals.
Methods: For investigation, 80 AML individuals and 20 healthy controls were selected. This study was done in the cancer molecular pathology research center of Mashhad University of Medical Sciences (MUMS), Iran during 2017-2019. FLT3-ITD mutation was assessed by polymerase chain reaction (PCR); Real-time quantitative PCR was performed to measure the amount of MDR1 gene expression. Bone marrow and blood smears of patients were evaluated in terms of morphology. SPSS 16.0 was used for data analysis.
Results: FLT3-ITD mutation and MDR1 overexpression were found in 18.8% and 23.8% of AML patients, respectively. Statistical analysis did not show any relations or association between these two markers. Cuplike morphology was observed in blast cells in 21.25% of AML cases, which was associated with FLT3-ITD mutation presence.
Conclusion: FLT-3 and MDR1 do not affect each other. It is suggested to perform survival studies to determine the exact role of MDR1 overexpression in drug resistance issues.
کلیدواژه‌های انگلیسی مقاله Acute myeloid leukemia (AML),Cuplike morphology,FLT3-ITD,Gene expression,Real-Time PCR (RT-PCR)
نویسندگان مقاله Ehsan Yazdandoust |
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran

Mohammad Hadidi Sadeghian |
Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Seyyede Fatemeh Shams |
Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran

Yasaman Saadatpour |
Laboratory science expert, Mashhad university of medical sciences, Mashhad, Iran

Payam Siyadat |
Departmant of Hemathology, School of Allied Medical Science, Iran University of Medical Science, Tehran,IRAN.

Maryam Sheikhi |
Cancer Molecular Pathology Research Center, Department of Hematology and Blood Bank, Mashhad University of Medical Sciences, Mashhad, Iran.

Monavar Afzal Aghaee |
Assistant professor of biostatistical sciences ,mashhad university of medical sciences, Mashhad University of Medical Sciences, Mashhad, Iran

Hossein Ayatollahi |
Cancer Molecular Pathology Research Center, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

نشانی اینترنتی https://ijp.iranpath.org/article_254802_9c9abe2cddce8d3c6e581b8246cc99be.pdf
فایل مقاله فایلی برای مقاله ذخیره نشده است
کد مقاله (doi)
زبان مقاله منتشر شده en
موضوعات مقاله منتشر شده
نوع مقاله منتشر شده
برگشت به: صفحه اول پایگاه   |   نسخه مرتبط   |   نشریه مرتبط   |   فهرست نشریات